Search
Returning search results with filters:
Remove filter for
Audience: Healthcare
Remove filter for
Category: Drugs
Remove filter for
Last updated: 2022
Clear all
Search filters
Type
Audience
Category
Issue
Last updated
- (-) 2022
- December 20224 results available
- November 20221 results available
- October 20222 results available
- September 20222 results available
- August 202211 results available
- July 20222 results available
- June 20229 results available
- May 20224 results available
- April 20223 results available
- March 202210 results available
- February 20226 results available
- January 20227 results available
Recall class
Displaying 1 - 15 of 61 items.
18F-Fludeoxyglucose (18F-FDG); Sterility concerns
RecallHealth product recall | 2022-12-14
NAT-Bendamustine: Discoloration
RecallHealth product recall | 2022-12-06
OCALIVA (obeticholic acid) – New Contraindication for the Treatment of Primary Biliary Cholangitis (PBC)
AlertHealth professional risk communication | 2022-12-05
Privigen: Series of adverse reactions
RecallHealth product recall | 2022-12-01
Canadian labelling for all JAK inhibitors to include risks of serious heart-related problems, fatal blood clots and cancer
AlertPublic advisory | 2022-11-01
Janus Kinase Inhibitors and the Risk of Major Adverse Cardiovascular Events, Thrombosis (Including Fatal Events) and Malignancy
AlertHealth professional risk communication | 2022-10-31
POTASSIUM CHLORIDE IN LACTATED RINGER'S INJECTION: Affected lot is labelled with the incorrect strength and ingredient
RecallHealth product recall | 2022-10-24
Menopur: Potential for a future out of specification result during shelf life
RecallHealth product recall | 2022-09-28
Lumi Lash: Unlicensed product with ingredient on prescription drug list.
RecallHealth product recall | 2022-09-26
Menopur: Out of specification (Assay)
RecallHealth product recall | 2022-08-31
DRAXIMAGE MDP: Affected lot may contain particulate matter
RecallHealth product recall | 2022-08-30
IMBRUVICA (ibrutinib) - Risk of Serious and Fatal Cardiac Arrhythmias or Cardiac Failure
AlertHealth professional risk communication | 2022-08-29
JAMP ATORVASTATIN CALCIUM: Affected lot may be labelled with the incorrect strength on the label.
RecallHealth product recall | 2022-08-29
PMS-Hydromorphone: Affected lot may contain tablets that could potentially lead to overdose
RecallHealth product recall | 2022-08-22
Jamp-Vitamin D: Out of Specification
RecallHealth product recall | 2022-08-22